Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
November 05, 2026 7.016
November 04, 2026 6.864
November 03, 2026 7.092
November 02, 2026 6.673
October 30, 2026 7.435
October 29, 2026 7.207
October 28, 2026 8.122
October 27, 2026 7.855
October 26, 2026 8.122
October 23, 2026 8.694
October 22, 2026 11.59
October 21, 2026 11.74
October 20, 2026 11.32
October 19, 2026 11.93
October 16, 2026 10.03
October 15, 2026 8.312
October 14, 2026 7.893
October 13, 2026 11.55
October 12, 2026 4.004
October 09, 2026 2.996
October 08, 2026 2.978
October 07, 2026 3.196
October 06, 2026 2.831
October 05, 2026 3.032
October 02, 2026 3.127
Date Value
October 01, 2026 3.508
September 30, 2026 3.384
September 29, 2026 3.662
September 28, 2026 3.889
September 25, 2026 4.156
September 24, 2026 4.309
September 23, 2026 4.385
September 22, 2026 4.843
September 21, 2026 4.804
September 18, 2026 4.576
September 17, 2026 6.101
September 16, 2026 4.881
September 15, 2026 5.376
September 14, 2026 5.681
September 11, 2026 5.758
September 10, 2026 5.947
September 09, 2026 5.948
September 08, 2026 5.986
September 04, 2026 6.215
September 03, 2026 6.292
September 02, 2026 6.368
September 01, 2026 6.330
August 31, 2026 6.482
August 28, 2026 6.120
August 27, 2026 6.330

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.28
Anika Therapeutics, Inc. 1.652
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 0.9579

Price to Book Value Related Metrics

PS Ratio 1377.74
Price 1.855
Earnings Yield -105.0%
Market Cap 4.612M